Mostrar el registro sencillo del ítem
Autor | Batista, Cassiano Martin | |
Autor | Foti, Leonardo | |
Fecha de acceso | 2021-11-12T17:08:03Z | |
Fecha de disponibilización | 2021-11-12T17:08:03Z | |
Fecha de publicación | 2021 | |
Referencia | BATISTA, Cassiano Martin. et al. Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives. Stem Cells International. v.99, n. 108036, p. 1–10, 2021. | pt_BR |
ISSN | 1567-5769 | pt_BR |
URI | https://www.arca.fiocruz.br/handle/icict/49819 | |
Idioma | por | pt_BR |
Editor | Elsevier | pt_BR |
Derechos de autor | open access | pt_BR |
Palabras clave en Portugués | SARS-CoV-2 | pt_BR |
Palabras clave en Portugués | COVID-19 | pt_BR |
Palabras clave en Portugués | SPIKE | pt_BR |
Palabras clave en Portugués | Imunoterapia Passiva | pt_BR |
Palabras clave en Portugués | Tempestade de Citocinas | pt_BR |
Título | Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives | pt_BR |
Tipo del documento | Article | pt_BR |
DOI | 10.1016/j.intimp.2021.108036 | |
Resumen en Inglés | Coronavirus disease 2019 (COVID-19) has been declared by the World Health Organization (WHO) as a pandemic since March 2020. This disease is caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). The only available tools to avoid contamination and transmission of this virus are physical distancing, the use of N95 and surgical masks, and hand hygiene. Vaccines are another essential tool to reduce the impact of the pandemic, though these present challenges in terms of production and logistics, particularly in underdeveloped and developing countries. One of the critical early research findings is the interaction of the spike virus protein with the angiotensin-converting enzyme 2 (ACE2) human receptor. Developing strategies to block this interaction has therefore been identified as a way to treat this infection. Neutralizing antibodies (nAbs) have emerged as a therapeutic approach since the pandemic started. Infected patients may be asymptomatic or present with mild symptoms, and others may evolve to moderate or severe disease, leading to death. An immunological phenomenon known as cytokine storm has been observed in patients with severe disease characterized by a proinflammatory cytokine cascade response that leads to lung injury. Thus, some treatment strategies focus on anti-cytokine storm nAbs. This review summarizes the latest advances in research and clinical trials, challenges, and perspectives on antibody-based treatments (ABT) as therapies against COVID-19. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Molecular e Sistêmica de Tripanossomatídeos. Curitiba, PR, Brasil. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Instituto Carlos Chagas. Laboratório de Biologia Molecular e Sistêmica de Tripanossomatídeos. Curitiba, PR, Brasil. | pt_BR |
Palavras clave en Inglês | Spike Glycoprotein, Coronavirus | pt_BR |
Palavras clave en Inglês | Immunization, Passive | pt_BR |
Palavras clave en Inglês | Antibodies, Neutralizing | pt_BR |
Palavras clave en Inglês | Cytokine Release Syndrome | pt_BR |
Palavras clave | Glicoproteína de la Espiga del Coronavirus | pt_BR |
Palavras clave | Inmunización Pasiva | pt_BR |
Palavras clave | Anticuerpos Neutralizantes | pt_BR |
Palavras clave | Síndrome de Liberación de Citoquinas | pt_BR |
Palavras clave en Francês | Glycoprotéine de spicule des coronavirus | pt_BR |
Palavras clave en Francês | Immunisation passive | pt_BR |
Palavras clave en Francês | Anticorps neutralisants | pt_BR |
DeCS | Glicoproteína da Espícula de Coronavírus | pt_BR |
DeCS | Imunização Passiva | pt_BR |
DeCS | Anticorpos Neutralizantes | pt_BR |
DeCS | Síndrome da Liberação de Citocina | pt_BR |